Laman UtamaDMYD-B • STO
add
Diamyd Medical AB
Tutup sebelumnya
kr 9.21
Julat hari
kr 9.34 - kr 10.50
Julat tahun
kr 7.50 - kr 25.00
Permodalan pasaran
1.28B SEK
Bilangan Purata
349.64K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(SEK) | Feb 2025info | Perubahan T/T |
---|---|---|
Hasil | 86.00K | 230.77% |
Perbelanjaan pengendalian | 44.69J | 59.86% |
Pendapatan bersih | -44.87J | -53.39% |
Margin untung bersih | -52.17K | 53.63% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -44.01J | -60.78% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(SEK) | Feb 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 103.75J | -24.35% |
Jumlah aset | 180.88J | -20.13% |
Jumlah liabiliti | 69.35J | 53.23% |
Jumlah ekuiti | 111.53J | — |
Syer tertunggak | 104.09J | — |
Harga kepada buku | 8.61 | — |
Pulangan pada aset | -56.58% | — |
Pulangan pada modal | -85.35% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(SEK) | Feb 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -44.87J | -53.39% |
Tunai daripada operasi | -48.41J | -36.64% |
Tunai daripada pelaburan | -458.00K | 86.82% |
Tunai daripada pembiayaan | -635.00K | -203.83% |
Perubahan bersih dalam tunai | -49.13J | -24.15% |
Aliran tunai bebas | -32.72J | -9.70% |
Perihal
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Diasaskan
1984
Tapak web
Pekerja
30